An ABCA4 loss-of-function mutation causes a canine form of Stargardt disease
Suvi MäkeläineniD, Marta GòdiaiD, Minas HellsandiD, Agnese ViļumaiD, Daniela Hahn, Karim MakdoumiiD, Caroline J. ZeissiD, Cathryn S. MellershiD, Sally L. RickettsiD, Kristina L. Narfström, Finn HallböökiD, Björn EkesteniD, Göran AnderssoniD, Tomas F. BergströmiD
Abstract
Autosomal recessive retinal degenerative diseases cause visual impairment and blindness in humans and dogs. Currently, no standard treatment is available but pioneering gene therapy-based canine models have been instrumental for clinical trials in humans. To study a novel form of retinal degeneration in Labrador retriever dogs with clinical signs indicating cone and rod degeneration, we used whole-genome sequencing of an affected sib-pair and their unaffected parents. A frameshift insertion in the ATP binding cassette subfamily A member 4 (ABCA4) gene (c.4176insC), leading to a premature stop codon in exon 28 (p.F1393Lfs1395) was identified. In contrast to unaffected dogs, no full-length ABCA4 protein was detected in the retina of an affected dog. The ABCA4 gene encodes a membrane transporter protein localized in the outer segments of rod and cone photoreceptors. In humans, the ABCA4 gene is associated with Stargardt disease (STGD), an autosomal recessive retinal degeneration leading to central visual impairment. A hallmark of STGD is the accumulation of lipofuscin deposits in the retinal pigment epithelium. The discovery of a canine homozygous ABCA4 loss-of-function mutation may advance the development of dog as a large animal model for human STGD.\n\nAuthor summaryStargardt disease (STGD) is the most common inherited retinal disease causing visual impairment and blindness in children and young adults, affecting 1 in 8-10 thousand people. For other inherited retinal diseases, the dog has become an established comparative animal model, both for identifying the underlying genetic causes and for developing new treatment methods.\n\nTo date, there is no standard treatment for STGD and the mouse model is the only available animal model to study the disease. As a nocturnal animal, the morphology of the mouse eye differs from humans and therefore the mouse model is not ideal for developing methods for treatment. We have studied a novel form of retinal degeneration in Labrador retrievers showing clinical signs similar to human STGD. To investigate the genetic cause of the disease, we used whole-genome sequencing of a family quartet including two affected offspring and their unaffected parents. This led to the identification of a loss-of-function mutation in the ABCA4 gene. The findings of this study may enable the development of a canine model for human STGD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 41
- FWCI
- 1.82
- Field percentile
- top 15%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Abca4 inhibition in a cone-rich rodent leads to Stargardt Disease type 1-like retinal degeneration
F. Sassone, D. Ciocca, … D. Hicks·bioRxiv·Sep 4, 2023
- Loss of ABCA4 from photoreceptor discs triggers changes in glial cell homeostasis
Rossella Valenzano, Andrew J. McDonald, … Jan Wijnholds·Stem CellsPeer-reviewed·Aug 10, 2026
- Pathogenic Mechanisms Underlying Stargardt Macular Degeneration Linked to Mutations in the Transmembrane Domains of ABCA4
F. A. Garces, J. F. Scortecci, R. S. Molday·bioRxiv·Aug 28, 2020
- Rescue of the Stargardt Disease phenotype in Abca4 knockout mice through dietary modulation of the vitamin A receptor RBPR2
Rakesh Radhakrishnan, Matthias Leung, … Glenn Prazere Lobo·FASEB BioAdvancesPeer-reviewed·Aug 1, 2025
- ABCA4-Related Retinopathies in Lebanon: a novel mutation and significant heterogeneity
Mariam Ibrahim, Lama Jaffal, … Saïd El Shamieh·medRxiv·Nov 9, 2023
- Compendium of clinical variant classification for 2,247 unique ABCA4 variants to improve genetic medicine access for Stargardt Disease
Stéphanie S. Cornelis, Miriam Bauwens, … Frans P.M. Cremers·medRxiv·Apr 24, 2023